Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Gewählte Publikation:
SHR Neuro Krebs Kardio Lipid Stoffw Microb
Hoetzenecker, K; Assinger, A; Lichtenauer, M; Mildner, M; Schweiger, T; Starlinger, P; Jakab, A; Berényi, E; Pavo, N; Zimmermann, M; Gabriel, C; Plass, C; Gyöngyösi, M; Volf, I; Ankersmit, HJ.
Secretome of apoptotic peripheral blood cells (APOSEC) attenuates microvascular obstruction in a porcine closed chest reperfused acute myocardial infarction model: role of platelet aggregation and vasodilation.
Basic Res Cardiol. 2012; 107(5): 292-292.
Doi: 10.1007/s00395-012-0292-2
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
- Co-Autor*innen der Med Uni Graz
- GABRIEL Christian
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- Although epicardial blood flow can be restored by an early intervention in most cases, a lack of adequate reperfusion at the microvascular level is often a limiting prognostic factor of acute myocardial infarction (AMI). Our group has recently found that paracrine factors secreted from apoptotic peripheral blood mononuclear cells (APOSEC) attenuate the extent of myocardial injury. The aim of this study was to determine the influence of APOSEC on microvascular obstruction (MVO) in a porcine AMI model. A single dose of APOSEC was intravenously injected in a closed chest reperfused infarction model. MVO was determined by magnetic resonance imaging and cardiac catheterization. Role of platelet function and vasodilation were monitored by means of ELISA, flow cytometry, aggregometry, western blot and myographic experiments in vitro and in vivo. Treatment of AMI with APOSEC resulted in a significant reduction of MVO. Platelet activation markers were reduced in plasma samples obtained during AMI, suggesting an anti-aggregatory capacity of APOSEC. This finding was confirmed by in vitro tests showing that activation and aggregation of both porcine and human platelets were significantly impaired by co-incubation with APOSEC, paralleled by vasodilator-stimulated phosphoprotein (VASP)-mediated inhibition of platelets. In addition, APOSEC evidenced a significant vasodilatory capacity on coronary arteries via p-eNOS and iNOS activation. Our data give first evidence that APOSEC reduces the extent of MVO during AMI, and suggest that modulation of platelet activation and vasodilation in the initial phase after myocardial infarction contributes to the improved long-term outcome in APOSEC treated animals.
- Find related publications in this database (using NLM MeSH Indexing)
- Animals -
- Cell Adhesion Molecules - physiology
- Cells, Cultured -
- Disease Models, Animal -
- Humans -
- In Vitro Techniques -
- Leukocytes, Mononuclear - physiology Leukocytes, Mononuclear - secretion
- Microfilament Proteins - physiology
- Myocardial Infarction - therapy
- Phosphoproteins - physiology
- Platelet Activation -
- Platelet Aggregation -
- Swine -
- Vasodilation -
- Find related publications in this database (Keywords)
- Microvascular obstruction
- Acute myocardial infarction
- Platelet function
- Vasodilation
- No-reflow
- PBMC
- Paracrine factors